FindTrial
Sign In

The study of contrast agent injection pattern in the four dimensional CT enhanced scanning for thoracic tumor radiotherapy

The study of contrast agent injection pattern in the four dimensional CT enhanced scanning for thoracic tumor radiotherapy

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-DDD-16009645
Enrollment
Unknown
Registered
2016-10-27
Start date
2016-11-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chest tumor

Interventions

Gold Standard:
Index test:

Sponsors

Xinqiao Hospital, Third Military Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
25 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. aged between 25-65 years old; 2. patients with lung cancer; 3. signed informed consent.

Exclusion criteria

Exclusion criteria: 1. patients with heart failure, hypertension, thrombosis and bleeding etc.

Design outcomes

Primary

MeasureTime frame
enhancement effect of contrast agent;—

Countries

China

Contacts

Public ContactHongya Dai

Institute of Cancer Research of People's Liberation Army, Xinqiao Hospital, Third Military Medical University, Chongqing

dhycumt@163.com+86 13140246045

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026